Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ
US Stock MarketDetailed Quotes
ICLR Icon PLC
- 143.020
- +0.060+0.04%
Close May 5 16:00 ET
- 143.020
- 0.0000.00%
Post 16:31 ET
11.36BMarket Cap15.58P/E (TTM)
144.995High140.460Low1.40MVolume144.220Open142.960Pre Close201.29MTurnover1.79%Turnover Ratio15.01P/E (Static)79.46MShares347.72352wk High1.20P/B11.20BFloat Cap133.28052wk Low--Dividend TTM78.33MShs Float347.723Historical High--Div YieldTTM3.17%Amplitude2.500Historical Low143.747Avg Price1Lot Size
About Icon PLC Company
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
Company Profile
SymbolICLR
Company NameIcon PLC
Listing DateMay 15, 1998
Issue Price18.00
Founded1989
CEODr. Steven Cutler, PhD
MarketNASDAQ
Employees41900
Fiscal Year Ends12-31
AddressSouth County Business Park,Leopardstown
CityDublin
ProvinceDublin
CountryIreland
Zip Code18
Phone353-1-291-2000
Websitehttp://www.iconplc.com
Company Executives
- Name
- Position
- Salary
- Dr. Steven Cutler, PhD
- Chief Executive Officer and Director
- 4.52M
- Nigel Clerkin
- Chief Financial Officer
- 247.00K
- Diarmaid Cunningham
- Chief Administrative Officer, General Counsel and Company Secretary
- --
- Barry Balfe
- Chief Operating Officer
- --
- Ciaran Murray
- Chairman of the Board
- 658.00K
- Julie O'Neill
- Independent Director
- 336.00K
- Anne Michelle Clem Whitaker
- Independent Director
- 50.00K
- Ronan Murphy
- Lead Independent Director
- 387.00K
- Eugene McCague
- Independent Director
- 343.00K
- Dr. Linda S. Grais, J.D.,M.D.
- Independent Director
- 332.00K
- Dr. John Climax
- Independent Director
- 311.00K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
